Polpharma Biologics & Fresenius Kabi enter licensing agreement for proposed vedolizumab biosimilar, PB016: Amsterdam Wednesday, August 6, 2025, 11:00 Hrs [IST] Polpharma Biologics ...

Ascletis completes enrollment in US phase IIa study of small molecule oral GLP-1R agonist, ASC30 to treat obesity: Hong Kong Wednesday, August 6, 2025, 10:00 Hrs [IST] Ascletis Ph ...

BD businesses become first in medtech to achieve HIRC's Diamond Badge across all supply chain resiliency categories: Franklin Lakes, New Jersey Wednesday, August 6, 2025, 09:00 Hr ...

DISSO ASIA 2025, Jakarta initiates India–Indonesia scientific collaboration: Shardul Nautiyal, Mumbai Wednesday, August 6, ...

Peethaambaran Kunnathoor, Chennai Wednesday, August 6, 2025, 08:00 Hrs [IST] ...

India needs Special Task Force led by IPS officer to strengthen narcotics surveillance: B Thirunavukkarasu: Nandita Vijayasimha, Bengaluru Wednesday, August 6, 2025, 08:00 Hrs [IS ...

RDI scheme set to ignite scientific breakthroughs & foster real-world innovation: Aditya Sharma: Nandita Vijayasimha, Bengaluru Wednesday, August 6, 2025, 08:00 Hrs [IST] India is ...

Pharmexcil to discuss key issues related to exports with Saudi Arabia for potential collaborations: Shardul Nautiyal, Mumbai Wednesday, August 6, 2025, 08:00 Hrs [IST] The Pharmac ...

Ramesh Shankar Wednesday, August 6, 2025, 08:00 Hrs [IST] In a formal communication to Union Minister of State for Health and Family Welfare Anupriya Patel ...

NPPA rejects Sun Pharma’s application for separate price for its antibiotic oral suspension: Gireesh Babu, New Delhi Wednesday, August 6, 2025, 08:00 Hrs [IST] The National Phar ...

Neurorehabilitation: Transforming lives via interdisciplinary approach for atypical Parkinsonism: Dr. Vignesh Srinivasan & Dr. Poovarasan Wednesday, August 6, 2025, 08:00 Hrs [IST ...

Anixa Biosciences commences US FDA approved IND transfer to support upcoming phase 2 breast cancer vaccine trial: San Jose, California Tuesday, August 5, 2025, 18:00 Hrs [IST] Ani ...